SweDeliver and NextBioForm launch dates for autumn webinars

2022-06-20

SweDeliver and NextBioForm will continue their joint webinars throughout the autumn term of 2022. The dates are are now available to experience presentations from the centers' junior researchers, special guest lectures and meetings with industrial partners. Welcome online August 25 for the first webinar of the autumn.

"SweDeliver's and NextBioForm's joint webinars continue to meet great interest, and we can now confirm a continuation with eight new dates throughout the autumn semester 2022,” states Alexandra Teleki, Center co-Director at SweDeliver and Associate senior lecturer at the Department of Pharmacy.

Save the dates: SweDeliver and NextBioForm webinars HT22

  • 25 August 2022
  • 22 September 2022
  • 6 October 2022
  • 20 October 2022
  • 3 November 2022
  • 17 November 2022
  • 1 December 2022
  • 15 December 2022

The webinars are held on Teams every other Thursday at 12.15-13.00h CET, starting 25 August and continuing until 15 December. Invitations to each session will be sent out separately. Please forward the meeting invitations to interested people in your organisations!

The webinars include short research updates with the latest developments from both competence centers, guest lecturers and presentations by industrial partners, ranging from big pharma to innovative SMEs.

FACTS

  • SweDeliver is a national competence center in drug delivery. With Uppsala University's Faculty of Pharmacy as the academic hub and 16 industrial partners, SweDeliver conducts research on parenteral, oral and pulmonary administration.
  • NextBioForm is a center with 18 partners, providing cutting edge research on industrially relevant issues for formulation and characterisation of biologically based drug products.

MORE INFORMATION

CONTACT

Alexandra Teleki portraitAlexandra Teleki, Uppsala university
Center co-Director, SweDeliver
alexandra.teleki@farmaci.uu.se

text: Magnus Alsne, photo: Mikael Wallerstedt

Currently at SweDeliver

Last modified: 2022-03-31